Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Nature

Volumn 426, Issue 6965, 2003, Pages 450-454

  Li, Wenhui ^a   Moore, Michael J ^a   Vasllieva, Natalya ^b   Sui, Jianhua ^c   Wong, Swee Kee ^a   Berne, Michael A ^d   Somasundaran, Mohan ^e   Sullivan, John L ^e   Luzuriaga, Katherine ^e   Greeneugh, Thomas C ^e   Choe, Hyeryun ^b   Farzan, Michael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ASSOCIATION REACTIONS; CELLS; PULMONARY DISEASES; VIRUSES;

CELLULAR RECEPTORS; SEVERE ACUTE RESPIRATORY SYNDROME (SARS);

ENZYMES;

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

BIOCHEMISTRY; PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; ENZYME ISOLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION;

ANIMALS; ANTIBODIES; CARBOXYPEPTIDASES; CELL LINE; CERCOPITHECUS AETHIOPS; GIANT CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR WEIGHT; PEPTIDYL-DIPEPTIDASE A; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SARS VIRUS; SOLUBILITY; TRANSFECTION; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SARS CORONAVIRUS;

EID: 0344395657     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02145     Document Type: Article

References (30)

1. Gallagher, T. M. & Buchmeler, M. J. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279, 371-374 (2001).
2. Holmes, K. V. SARS-associated coronavirus. N. Engl. J. Med. 348, 1948-1951 (2003).
3. Donoghue, M. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin 1 to angiotensin 1-9. Circ. Res. 87, E1-E9 (2000).
4. Tipnis S. R. et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243 (2000).
5. Holmes, K. V. et al. Coronavirus receptor specificity. Adv. Exp. Med. Biol. 342, 261-266 (1993).
6. Dveksler, G. S. et al. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67, 1-8 (1993).
7. Delmas, B. et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV Nature 357, 417-420 (1992).
8. Tresnan, D. B. & Holmes, K. V. Feline aminopeptidase N is a receptor for all group I coronaviruses. Adv. Exp. Med. Biol. 440, 69-75 (1998).
9. Yeager, C. L. et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357, 420-422 (1992).
10. Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953-1966 (2003).
11. Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967-1976 (2003).
12. Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263-270 (2003).
13. Fouchier, R. A. et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240 (2003).
14. Rota, P. A. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394-1399 (2003).
15. Marra, M. A. et al. The Genome sequence of the SARS-associated coronavirus. Science 300, 1399-1404 (2003).
16. Sturman, L. S. & Holmes, K. V. Proteolytic cleavage of peplomeric glycoprotein E2 of MHV yields two 90K subunits and activates cell fusion. Adv. Exp. Med. Biol. 173, 25-35 (1984).
17. Jackwood, M. W. et al. Spike glycoprotein cleavage recognition site analysis of infectious bronchitis virus. Avian Dis. 45, 366-372 (2001).
18. Spaan, W., Cavanagh, D. & Horzinek, M. C. Coronaviruses: structure and genome expression. J. Gen. Virol. 69, 2939-2952 (1988).
19. Bonavia, A., Zelus, B. D., Wentworth, D. E., Talbot, P. J. & Holmes, K. V. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J. Virol. 77, 2530-2538 (2003).
20. Breslin, J. J. et al. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C. J. Virol. 77, 4435-4438 (2003).
21. Kubo, H., Yamada, Y. K. & Taguchi, F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68, 3403-5410 (1994).
22. Komatsu, T. et al. Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxy peptidase (mACE2). DNA Seq. 13, 217-220 (2002).
23. Harmer, D., Gilbert, M., Borman, R. & Clark, K. L. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 532, 107-110 (2002).
24. Choe, H. et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).
25. Leung, W. K. et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125, 1011-1017 (2003).
26. Crackower, M. A. et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 822-828 (2002).
27. Vickers, C. et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277, 14838-14843 (2002).
28. Delmas, B. et al. Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J. Virol. 68, 5216-5224 (1994).
29. Huang, L. et al. Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem. 278, 15532-15540 (2003).
30. Dales, N. A. et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 124, 11852-11853 (2002).